Immunology taught by human genetics

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 78, Issue 1, 2013, Pages 157-172

  Casanova, Jean Laurent ^a,b,c   Abel, Laurent ^a,b,c   Quintana Murci, Lluis ^d,e  

^a ROCKEFELLER UNIVERSITY   (United States)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d INSTITUT PASTEUR   (France)

^e CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ANTIBIOTIC THERAPY; ARTICLE; AUTOIMMUNITY; COMMENSAL; DISEASE PREDISPOSITION; EVOLUTION; GENE FUNCTION; GENE LOCUS; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC SELECTION; GENETIC VARIABILITY; HERITABILITY; HUMAN; IMMUNITY; IMMUNOGENETICS; IMMUNOLOGICAL TOLERANCE; LIFE EXPECTANCY; MOLECULAR GENETICS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; VACCINATION; ALLELE; CHEMISTRY; COMMUNICABLE DISEASE; CYTOLOGY; GENETICS; GENOMICS; HUMAN GENOME; IMMUNE DEFICIENCY; IMMUNOLOGICAL TECHNIQUE; INFECTIOUS DISEASE MEDICINE; MEDICAL GENETICS; METHODOLOGY; MOLECULAR EPIDEMIOLOGY; MUTATION; PROCEDURES; STEM CELL;

DNA; STAT1 PROTEIN; STAT1 PROTEIN, HUMAN;

ALLELES; BIOLOGICAL EVOLUTION; COMMUNICABLE DISEASES; DNA; GENETICS, MEDICAL; GENOME, HUMAN; GENOMICS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOLOGIC TECHNIQUES; INFECTIOUS DISEASE MEDICINE; MOLECULAR EPIDEMIOLOGY; MUTATION; PHENOTYPE; RESEARCH DESIGN; STAT1 TRANSCRIPTION FACTOR; STEM CELLS;

EID: 84904916672     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2013.78.019968     Document Type: Article

References (213)

1. Abadie V, Sollid LM, Barreiro LB, Jabri B. 2011. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol 29: 493-525.
2. Abi-Rached L, Jobin MJ, Kulkarni S, McWhinnie A, Dalva K, Gragert L, Babrzadeh F, Gharizadeh B, Luo M, Plummer FA, et al. 2011. The shaping of modern human immune systems by multiregional admixture with archaic humans. Science 334: 89-94.
3. Abramson J, Giraud M, Benoist C, Mathis D. 2010. Aire's partners in the molecular control of immunological tolerance. Cell 140: 123-135.
4. Aganna E, Martinon F, Hawkins PN, Ross JB, Swan DC, Booth DR, Lachmann HJ, Bybee A, Gaudet R, Woo P, et al. 2002. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum 46: 2445-2452.
5. Alcais A, Abel L. 2004. Application of genetic epidemiology to dissecting host susceptibility/resistance to infection illustrated with the study of common mycobacterial infections. In Susceptibility to infectious diseases: The importance of host genetics (ed. Bellamy R), pp. 7-44. Cambridge University Press, New York.
6. Alcais A, Alter A, Antoni G, Orlova M, Van Thuc N, Singh M, Vanderborght PR, Katoch K, Mira MT, Thai VH, et al. 2007. Stepwise replication identifies a low-producing lymphotoxina allele as a major risk factor for early-onset leprosy. Nat Genet 39: 517-522.
7. Alcais A, Abel L, Casanova JL. 2009a. Human genetics of infectious diseases. In Human genetics: Problems and approaches (eds. Vogel F, et al.), pp. 403-415. Springer, Berlin.
8. Alcais A, Abel L, Casanova JL. 2009b. Human genetics of infectious diseases: Between proof of principle and paradigm. J Clin Invest 119: 2506-2514.
9. Alcais A, Quintana-Murci L, Thaler DS, Schurr E, Abel L, Casanova JL. 2010. Life-threatening infectious diseases of childhood: Single-gene inborn errors of immunity? Ann N Y Acad Sci 1214: 18-33.
10. Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, Etzioni A, Fischer A, Franco JL, Geha RS, et al. 2011. Primary immunodeficiency diseases:An update on the classification from the International Union of Immunological Societies expert committee for primary immunodeficiency. Front Immunol 2: 54.
11. Allison AC. 1954. Protection afforded by sickle cell trait against subtertian malarian infection. Br Med J 1: 290-294.
12. Al-Muhsen S, Casanova JL. 2008. The genetic heterogeneity of Mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol 122: 1043-1051; quiz 1052-1043.
13. Ambati J, Atkinson J, Gelfand BD. 2013. Immunology of agerelated macular degeneration. Nat Rev Immunol 13: 438-451.
14. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, et al. 2002. Projection of an immunological self shadow within the thymus by the aire protein. Science 298: 1395-1401.
15. Appleby MW, Ramsdell F. 2008. Scurfy, the Foxp3 locus, and the molecular basis of peripheral tolerance. Curr Top Microbiol Immunol 321: 151-168.
16. Baghdadi JE, Orlova M, Alter A, Ranque B, Chentoufi M, Lazrak F, Archane MI, Casanova JL, Benslimane A, Schurr E, et al. 2006. An autosomal dominant major gene confers predisposition to pulmonary tuberculosis in adults. J Exp Med 203: 1679-1684.
17. Barreiro LB, Quintana-Murci L. 2010. From evolutionary genetics to human immunology: How selection shapes host defence genes. Nat Rev Genet 11: 17-30.
18. Barreiro LB, Laval G, Quach H, Patin E, Quintana-Murci L. 2008. Natural selection has driven population differentiation in modern humans. Nat Genet 40: 340-345.
19. Barreiro LB, Ben-Ali M, Quach H, Laval G, Patin E, Pickrell JK, Bouchier C, Tichit M, Neyrolles O, Gicquel B, et al. 2009. Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense. PLoS Genet 5: e1000562.
20. Bernard C. 1865. Introduction à l'étude de la médecine expérimentale. Baillière, Paris.
21. Beutler B, Du X, Xia Y. 2007. Precis on forward genetics in mice. Nat Immunol 8: 659-664.
22. Bibert S, Roger T, Calandra T, Bochud M, Cerny A, Semmo N, Duong FH, Gerlach T, Malinverni R, Moradpour D, et al. 2013. IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction. J Exp Med 210: 1109-1116.
23. Blackwell JM, Jamieson SE, Burgner D. 2009. HLA and infectious diseases. Clin Microbiol Rev 22: 370-385.
24. Blekhman R, Man O, Herrmann L, Boyko AR, Indap A, Kosiol C, Bustamante CD, Teshima KM, Przeworski M. 2008. Natural selection on genes that underlie human disease susceptibility. Curr Biol 18: 883-889.
25. Bogunovic D, Byun M, Durfee LA, Abhyankar A, Sanal O, Mansouri D, Salem S, Radovanovic I, Grant AV, Adimi P, et al. 2012. Mycobacterial disease and impaired IFN-g immunity in humans with inherited ISG15 deficiency. Science 337: 1684-1688.
26. Bogunovic D, Boisson-Dupuis S, Casanova JL. 2013. ISG15:Leading a double life as a secreted molecule. Exp Mol Med 45: e18.
27. Boisson B, Laplantine E, Prando C, Giliani S, Israelsson E, Xu Z, Abhyankar A, Israel L, Trevejo-Nunez G, Bogunovic D, et al. 2012. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat Immunol 13: 1178-1186.
28. Boisson-Dupuis S, Kong XF, Okada S, Cypowyj S, Puel A, Abel L, Casanova JL. 2012. Inborn errors of human STAT1: Allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr Opin Immunol 24: 364-378.
29. Bolze A, Mahlaoui N, Byun M, Turner B, Trede N, Ellis SR, Abhyankar A, Itan Y, Patin E, Brebner S, et al. 2013. Ribosomal protein SA haploinsufficiency in humans with isolated congenital asplenia. Science 340: 976-978.
30. Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, Etzioni A, Fischer A, Franco JL, Geha RS, et al. 2013a. A phenotypic approach for IUIS PID classification and diagnosis: Guidelines for clinicians at the bedside. J Clin Immunol 33: 1078-1087.
31. Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, Abel L. 2013b. Primary immunodeficiency diseases worldwide: More common than generally thought. J Clin Immunol 33: 1-7.
32. Buckley RH. 2004. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 22: 625-655.
33. Bustamante CD, Fledel-Alon A, Williamson S, Nielsen R, Hubisz MT, Glanowski S, Tanenbaum DM, White TJ, Sninsky JJ, Hernandez RD, et al. 2005. Natural selection on protein- coding genes in the human genome. Nature 437: 1153-1157.
34. Bustamante J, Arias AA, Vogt G, Picard C, Galicia LB, Prando C, Grant AV, Marchal CC, Hubeau M, Chapgier A, et al. 2011. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol 12: 213-221.
35. Byun M, Ma CS, Akçay A, Pedergnana V, Palendira U, Myoung J, Avery DT, Liu Y, Abhyankar A, Lorenzo L, et al. 2013. OX40 deficiency underlies childhood Kaposi sarcoma. J Exp Med 210: 1743-1759.
36. Cagliani R, Fumagalli M, Biasin M, Piacentini L, Riva S, Pozzoli U, Bonaglia MC, Bresolin N, Clerici M, Sironi M. 2010. Longterm balancing selection maintains trans-specific polymorphisms in the human TRIM5 gene. Hum Genet 128: 577-588.
37. Cairns J. 1997. Matters of life and death. Princeton University Press, Princeton, NJ.
38. Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ, Kaslow R, Buchbinder S, Hoots K, O'Brien SJ. 1999. HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage. Science 283: 1748-1752.
39. Casanova JL, Abel L. 2002. Genetic dissection of immunity to mycobacteria: The human model. Annu Rev Immunol 20: 581-620.
40. Casanova JL, Abel L. 2004. The human model: A genetic dissection of immunity to infection in natural conditions. Nat Rev Immunol 4: 55-66.
41. Casanova JL, Abel L. 2005. Inborn errors of immunity to infection:The rule rather than the exception. J Exp Med 202: 197-201.
42. Casanova JL, Abel L. 2007. Primary immunodeficiencies: A field in its infancy. Science 317: 617-619.
43. Casanova JL, Abel L. 2009. Revisiting Crohn's disease as a primary immunodeficiency of macrophages. J Exp Med 206: 1839-1843.
44. Casanova JL, Abel L. 2013. The genetic theory of infectious diseases: A brief history and selected illustrations. Annu Rev Genomics Hum Genet 14: 215-243.
45. Casanova JL, Abel L, Quintana-Murci L. 2011. Human TLRs and IL-1Rs in host defense: Natural insights from evolutionary, epidemiological, and clinical genetics. Annu Rev Immunol 29: 447-491.
46. Casanova JL, Conley ME, Notarangelo LD. 2013. Inborn errors of immunity. In Fundamental immunology, 7th ed. (ed. Paul WE), pp. 1235-1266. Lippincott Williams & Wilkins, Philadelphia.
47. Casrouge A, Zhang SY, Eidenschenk C, Jouanguy E, Puel A, Yang K, Alcais A, Picard C, Mahfoufi N, Nicolas N, et al. 2006. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314: 308-312.
48. 2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D. Science 341: 186-191.
49. Cheng MH, Anderson MS. 2012. Monogenic autoimmunity. Annu Rev Immunol 30: 393-427.
50. Chi CY, Chu CC, Liu JP, Lin CH, Ho MW, Lo WJ, Lin PC, Chen HJ, Chou CH, Feng JY, et al. 2013. Anti-IFN-γ autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLADQB1*05:02 and the reactivation of latent varicella-zoster virus infection. Blood 121: 1357-1366.
51. Cho JH, Gregersen PK. 2011. Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med 365: 1612-1623.
52. Cirulli ET, Goldstein DB. 2010. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 11: 415-425.
53. Concannon P, Erlich HA, Julier C, Morahan G, Nerup J, Pociot F, Todd JA, Rich SS. 2005. Type 1 diabetes: Evidence for susceptibility loci from four genome-wide linkage scans in 1435 multiplex families. Diabetes 54: 2995-3001.
54. Conley ME, Dobbs AK, Farmer DM, Kilic S, Paris K, Grigoriadou S, Coustan-Smith E, Howard V, Campana D. 2009. Primary B cell immunodeficiencies: Comparisons and contrasts. Annu Rev Immunol 27: 199-227.
55. Conley ME, Notarangelo LD, Casanova JL. 2011. Definition of primary immunodeficiency in 2011: A "trialogue" among friends. Ann NY Acad Sci 1238: 1-6.
56. Consortium (Finnish-German APECED). 1997. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 17: 399-403.
57. Cook MC, Vinuesa CG, Goodnow CC. 2006. ENU-mutagenesis:Insight into immune function and pathology. Curr Opin Immunol 18: 627-633.
58. Cooper GS, Miller FW, Pandey JP. 1999. The role of genetic factors in autoimmune disease: Implications for environmental research. Environ Health Perspect 107(suppl. 5): 693-700.
59. Cotsapas C, Voight BF, Rossin E, Lage K, Neale BM, Wallace C, Abecasis GR, Barrett JC, Behrens T, Cho J, et al. 2011. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet 7: e1002254.
60. Courtois G, Smahi A, Reichenbach J, Doffinger R, Cancrini C, Bonnet M, Puel A, Chable-Bessia C, Yamaoka S, Feinberg J, et al. 2003. A hypermorphic IκBα mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest 112: 1108-1115.
61. Dalmasso C, Carpentier W, Meyer L, Rouzioux C, Goujard C, Chaix ML, Lambotte O, Avettand-Fenoel V, Le Clerc S, de Senneville LD, et al. 2008. Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection:The ANRS Genome Wide Association 01 study. PLoS One 3: e3907.
62. Davis MM. 2012. Immunology taught by humans. Sci Transl Med 4: 117fs2.
63. de Beaucoudrey L, Samarina A, Bustamante J, Cobat A, Boisson-Dupuis S, Feinberg J, Al-Muhsen S, Janniere L, Rose Y, de Suremain M, et al. 2010. Revisiting human IL-12RΒ1 deficiency: A survey of 141 patients from 30 countries. Medicine 89: 381-402.
64. Derry JM, Ochs HD, Francke U. 1994. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 79: following 922.
65. Devriendt K, Kim AS, Mathijs G, Frints SG, Schwartz M, Van Den Oord JJ, Verhoef GE, Boogaerts MA, Fryns JP, You D, et al. 2001. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet 27: 313-317.
66. Di Rienzo A. 2006. Population genetics models of common diseases. Curr Opin Genet Dev 16: 630-636.
67. Duggal P, Thio CL,Wojcik GL, Goedert JJ, Mangia A, Latanich R, Kim AY, Lauer GM, Chung RT, Peters MG, et al. 2013. Genome-wide association study of spontaneous resolution of hepatitis C virus infection: Data from multiple cohorts. Ann Intern Med 158: 235-245.
68. Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, Farrer LA. 2005. Complement factor H polymorphism and age-related macular degeneration. Science 308: 421-424.
69. Emond MJ, Louie T, Emerson J, Zhao W, Mathias RA, Knowles MR, Wright FA, Rieder MJ, Tabor HK, Nickerson DA, et al. 2012. Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis. Nat Genet 44: 886-889.
70. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, Zhang K, Gumbs C, Castagna A, Cossarizza A, et al. 2007. A whole-genome association study of major determinants for host control of HIV-1. Science 317: 944-947.
71. Ferrer-Admetlla A, Sikora M, Laayouni H, Esteve A, Roubinet F, Blancher A, Calafell F, Bertranpetit J, Casals F. 2009. A natural history of FUT2 polymorphism in humans. Mol Biol Evol 26: 1993-2003.
72. Fieschi C, Dupuis S, Catherinot E, Feinberg J, Bustamante J, Breiman A, Altare F, Baretto R, Le Deist F, Kayal S, et al. 2003. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor Β1 deficiency: Medical and immunological implications. J Exp Med 197: 527-535.
73. Forabosco P, Bouzigon E, Ng MY, Hermanowski J, Fisher SA, Criswell LA, Lewis CM. 2009. Meta-analysis of genomewide linkage studies across autoimmune diseases. Eur J Hum Genet 17: 236-243.
74. Fornarino S, Laval G, Barreiro LB, Manry J, Vasseur E, Quintana-Murci L. 2011. Evolution of the TIR domain-containing adaptors in humans: Swinging between constraint and adaptation. Mol Biol Evol 28: 3087-3097.
75. Fumagalli M, Cagliani R, Pozzoli U, Riva S, Comi GP, Menozzi G, Bresolin N, Sironi M. 2009a.Widespread balancing selection and pathogen-driven selection at blood group antigen genes. Genome Res 19: 199-212.
76. Fumagalli M, Pozzoli U, Cagliani R, Comi GP, Riva S, Clerici M, Bresolin N, Sironi M. 2009b. Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions. J Exp Med 206:1395-1408.
77. Fumagalli M, Sironi M, Pozzoli U, Ferrer-Admetlla A, Pattini L, Nielsen R. 2011. Signatures of environmental genetic adaptation pinpoint pathogens as the main selective pressure through human evolution. PLoS Genet 7: e1002355.
78. Gardner JM, Devoss JJ, Friedman RS,Wong DJ, Tan YX, Zhou X, Johannes KP, Su MA, Chang HY, Krummel MF, et al. 2008. Deletional tolerance mediated by extrathymic Aire-expressing cells. Science 321: 843-847.
79. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, et al. 2009. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461: 399-401.
80. Gendzekhadze K, Norman PJ, Abi-Rached L, Graef T, Moesta AK, Layrisse Z, Parham P. 2009. Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands. Proc Natl Acad Sci 106: 18692-18697.
81. Gineau L, Cognet C, Kara N, Lach FP, Dunne J, Veturi U, Picard C, Trouillet C, Eidenschenk C, Aoufouchi S, et al. 2012. Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency. J Clin Invest 122: 821-832.
82. Good RA. 1991. Experiments of nature in the development of modern immunology. Immunol Today 12: 283-286.
83. Goris A, Liston A. 2012. The immunogenetic architecture of autoimmune disease. Cold Spring Harb Perspect Biol 4: a007260.
84. Goulder PJ, Watkins DI. 2008. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 8: 619-630.
85. Grant AV, El Baghdadi J, Sabri A, El Azbaoui S, Alaoui-Tahiri K, Abderrahmani Rhorfi I, Gharbaoui Y, Abid A, Benkirane M, Raharimanga V, et al. 2013. Age-dependent association between pulmonary tuberculosis and common TOX variants in the 8q12-13 linkage region. Am J Hum Genet 92: 407-414.
86. Grossman SR, Andersen KG, Shlyakhter I, Tabrizi S, Winnicki S, Yen A, Park DJ, Griesemer D, Karlsson EK, Wong SH, et al. 2013. Identifying recent adaptations in large-scale genomic data. Cell 152: 703-713.
87. Guo Y, Audry M, Ciancanelli M, Alsina L, Azevedo J, Herman M, Anguiano E, Sancho-Shimizu V, Lorenzo L, Pauwels E, et al. 2011. Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J Exp Med 208: 2083-2098.
88. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, et al. 2005. Complement factor H variant increases the risk of age-related macular degeneration. Science 308: 419-421.
89. Hamblin MT, Thompson EE, Di Rienzo A. 2002. Complex signatures of natural selection at the Duffy blood group locus. Am J Hum Genet 70: 369-383.
90. Hawkins RD, Hon GC, Ren B. 2010. Next-generation genomics:An integrative approach. Nat Rev Genet 11: 476-486.
91. Hawn TR, Misch EA, Dunstan SJ, Thwaites GE, Lan NT, Quy HT, Chau TT, Rodrigues S, Nachman A, Janer M, et al. 2007. A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur J Immunol 37: 2280-2289.
92. Hirayasu K, Ohashi J, Tanaka H, Kashiwase K, Ogawa A, Takanashi M, Satake M, Jia GJ, Chimge NO, Sideltseva EW, et al. 2008. Evidence for natural selection on leukocyte immunoglobulin- like receptors for HLA class I in Northeast Asians. Am J Hum Genet 82: 1075-1083.
93. Hoffman HM, Mueller JL, Broide DH,Wanderer AA, Kolodner RD. 2001. Mutation of a new gene encoding a putative pyrinlike protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 29: 301-305.
94. Hughes CR, Guasti L, Meimaridou E, Chuang CH, Schimenti JC, King PJ, Costigan C, Clark AJ, Metherell LA. 2012. MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans. J Clin Invest 122: 814-820.
95. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, et al. 1996. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379: 821-823.
96. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
97. Hunt KA, Mistry V, Bockett NA, Ahmad T, Ban M, Barker JN, Barrett JC, Blackburn H, Brand O, Burren O, et al. 2013. Negligible impact of rare autoimmune-locus coding-region variants on missing heritability. Nature 498: 232-235.
98. Husebye ES, Anderson MS. 2010. Autoimmune polyendocrine syndromes: Clues to type 1 diabetes pathogenesis. Immunity 32: 479-487.
99. Itan Y, Zhang SY, Vogt G, Abhyankar A, Herman M, Nitschke P, Fried D, Quintana-Murci L, Abel L, Casanova JL. 2013. The human gene connectome as a map of short cuts for morbid allele discovery. Proc Natl Acad Sci 110: 5558-5563.
100. Johnson CM, Lyle EA, Omueti KO, Stepensky VA, Yegin O, Alpsoy E, Hamann L, Schumann RR, Tapping RI. 2007. Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J Immunol 178: 7520-7524.
101. Jostins L, Ripke S,Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, et al. 2012. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491: 119-124.
102. Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile JF, Newport M, Levin M, Blanche S, Seboun E, Fischer A, et al. 1996. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med 335: 1956-1961.
103. Jouanguy E, Lamhamedi-Cherradi S, Lammas D, Dorman SE, Fondanèche M-C, Dupuis S, Döffinger R, Altare F, Emile J-F, Girdelstone J, et al. 1999. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet 21: 370-378.
104. Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, Kubo M, Tsunoda T, Kamatani N, Kumada H, et al. 2009. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 41: 591-595.
105. Kavanagh D, Richards A, Atkinson J. 2008. Complement regulatory genes and hemolytic uremic syndromes. Annu Rev Med 59: 293-309.
106. Khoury MJ, Beaty TH, Cohen BH. 1993. Fundamentals of genetic epidemiology. Oxford University Press, New York.
107. Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, Chetty S, Rathnavalu P, Moore C, Pfafferott KJ, Hilton L, et al. 2004. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 432: 769-775.
108. Kisand K, Bøe Wolff AS, Podkrajsek KT, Tserel L, Link M, Kisand KV, Ersvaer E, Perheentupa J, Erichsen MM, Bratanic N, et al. 2010. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med 207: 299-308.
109. Klein J, Satta Y, O'Huigin C, Takahata N. 1993. The molecular descent of the major histocompatibility complex. Annu Rev Immunol 11: 269-295.
110. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, San Giovanni JP, Mane SM, Mayne ST, et al. 2005. Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389.
111. Knight JC. 2013. Genomic modulators of the immune response. Trends Genet 29: 74-83.
112. Kong XF, Vogt G, Itan Y, Macura-Biegun A, Szaflarska A, Kowalczyk D, Chapgier A, Abhyankar A, Furthner D, Djambas Khayat C, et al. 2013. Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease. Hum Mol Genet 22: 769-781.
113. Kotlarz D, Zietara N, Uzel G, Weidemann T, Braun CJ, Diestelhorst J, Krawitz PM, Robinson PN, Hecht J, Puchalka J, et al. 2013. Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome. J Exp Med 210: 433-443.
114. Krawczyk M, Reith W. 2006. Regulation of MHC class II expression, a unique regulatory system identified by the study of a primary immunodeficiency disease. Tissue Antigens 67: 183-197.
115. Krebs HA. 1975. The August Krogh principle: "For many problems there is an animal on which it can be most conveniently studied". J Exp Zool 194: 221-226.
116. Krogh A. 1929. The progress of physiology. Science 70: 200-204.
117. Kryukov GV, Pennacchio LA, Sunyaev SR. 2007. Most rare missense alleles are deleterious in humans: Implications for complex disease and association studies. Am J Hum Genet 80: 727-739.
118. Ku CL, von Bernuth H, Picard C, Zhang SY, Chang HH, Yang K, Chrabieh M, Issekutz AC, Cunningham CK, Gallin J, et al. 2007. Selective predisposition to bacterial infections in IRAK-4 deficient children: IRAK-4 dependent TLRs are otherwise redundant in protective immunity. J Exp Med 204: 2407-2422.
119. Lafaille FG, Pessach IM, Zhang SY, Ciancanelli MJ, Herman M, Abhyankar A, Ying SW, Keros S, Goldstein PA, Mostoslavsky G, et al. 2012. Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature 491: 769-773.
120. Laird NM, Lange C. 2006. Family-based designs in the age of large-scale gene-association studies. Nat Rev Genet 7: 385-394.
121. Leffler EM, Gao Z, Pfeifer S, Segurel L, Auton A, Venn O, Bowden R, Bontrop R,Wall JD, Sella G, et al. 2013. Multiple instances of ancient balancing selection shared between humans and chimpanzees. Science 339: 1578-1582.
122. Leslie A, Matthews PC, Listgarten J, Carlson JM, Kadie C, Ndung'u T, Brander C, Coovadia H, Walker BD, Heckerman D, et al. 2010. Additive contribution of HLA class I alleles in the immune control of HIV-1 infection. J Virol 84: 9879-9888.
123. 2+ revealed by human T-cell immunodeficiency. Nature 475: 471-476.
124. Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, Toubiana J, Itan Y, Audry M, Nitschke P, et al. 2011. Gain-offunction human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 208: 1635-1648.
125. Louicharoen C, Patin E, Paul R, Nuchprayoon I, Witoonpanich B, Peerapittayamongkol C, Casademont I, Sura T, Laird NM, Singhasivanon P, et al. 2009. Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians. Science 326: 1546-1549.
126. MacArthur DG, Balasubramanian S, Frankish A, Huang N, Morris J,Walter K, Jostins L, Habegger L, Pickrell JK, Montgomery SB, et al. 2012. A systematic survey of loss-of-function variants in human protein-coding genes. Science 335: 823-828.
127. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, et al. 2009. Finding the missing heritability of complex diseases. Nature 461: 747-753.
128. Manry J, Laval G, Patin E, Fornarino S, Itan Y, Fumagalli M, Sironi M, Tichit M, Bouchier C, Casanova JL, et al. 2011. Evolutionary genetic dissection of human interferons. J Exp Med 208: 2747-2759.
129. Martin MP, Carrington M. 2005. Immunogenetics of viral infections. Curr Opin Immunol 17: 510-516.
130. Masters SL, Simon A, Aksentijevich I, Kastner DL. 2009. Horror autoinflammaticus: The molecular pathophysiology of autoinflammatory disease (*). Annu Rev Immunol 27: 621-668.
131. McQuarrie I. 1944. The experiments of nature and other essays. University of Kansas Press, Lawrence, KS.
132. Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, Martino L, Hallahan CW, Selig SM, Schwartz D, Sullivan J, et al. 2000. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIVinfected long term nonprogressors. Proc Natl Acad Sci 97: 2709-2714.
133. Mira MT, Alcais A, Van Thuc N, Thai VH, Huong NT, Ba NN, Verner A, Hudson TJ, Abel L, Schurr E. 2003. Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population. Nat Genet 33: 412-415.
134. Mira MT, Alcais A, Nguyen VT, Moraes MO, Di Flumeri C, Vu HT, Mai CP, Nguyen TH, Nguyen NB, Pham XK, et al. 2004. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 427: 636-640.
135. Moshous D, Callebaut I, de Chasseval R, Corneo B, Cavazzana-Calvo M, Le Deist F, Tezcan I, Sanal O, Bertrand Y, Philippe N, et al. 2001. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105: 177-186.
136. Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJ, Lalioti MD, Mullis PE, Antonarakis SE, et al. 1997. Positional cloning of the APECED gene. Nat Genet 17: 393-398.
137. Nakajima T, Ohtani H, Satta Y, Uno Y, Akari H, Ishida T, Kimura A. 2008. Natural selection in the TLR-related genes in the course of primate evolution. Immunogenetics 60: 727-735.
138. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, Levin M. 1996. A mutation in the interferon- g-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 335: 1941-1949.
139. Nielsen R. 2005. Molecular signatures of natural selection. Annu Rev Genet 39: 197-218.
140. Nielsen R, Hellmann I, Hubisz M, Bustamante C, Clark AG. 2007. Recent and ongoing selection in the human genome. Nat Rev Genet 8: 857-868.
141. Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW, Leonard WJ. 1993. Interleukin-2 receptor g chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73: 147-157.
142. Notarangelo LD. 2013. Functional T-cell immunodeficiencies (with T cells present). Annu Rev Immunol 31: 195-225.
143. Notarangelo LD, Gambineri E, Badolato R. 2006. Immunodeficiencies with autoimmune consequences. Adv Immunol 89: 321-370.
144. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, et al. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606.
145. Pachlopnik Schmid J, Cote M, Menager MM, Burgess A, Nehme N, Menasche G, Fischer A, de Saint Basile G. 2010. Inherited defects in lymphocyte cytotoxic activity. Immunol Rev 235: 10-23.
146. Parham P, Moffett A. 2013. Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat Rev Immunol 13: 133-144.
147. Parham P, Norman PJ, Abi-Rached L, Guethlein LA. 2012. Human-specific evolution of killer cell immunoglobulinlike receptor recognition of major histocompatibility complex class I molecules. Philos Trans R Soc Lond B Biol Sci 367: 800-811.
148. Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, et al. 2010. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330: 1551-1557.
149. Perez de Diego R, Sancho-Shimizu V, Lorenzo L, Puel A, Plancoulaine S, Picard C, Herman M, Cardon A, Durandy A, Bustamante J, et al. 2010. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 33: 400-411.
150. Pessach I, Walter J, Notarangelo L. 2009. Recent advances in primary immunodeficiencies: Identification of novel genetic defects and unanticipated phenotypes. Pediatr Res 65: 3R-10R.
151. Phillips RE. 2002. Immunology taught by Darwin. Nat Immunol 3: 987-989.
152. Picard C, Puel A, Bonnet M, Ku CL, Bustamante J, Yang K, Soudais C, Dupuis S, Feinberg J, Fieschi C, et al. 2003. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299: 2076-2079.
153. Picard C, von Bernuth H, Ghandil P, Chrabieh M, Levy O, Arkwright PD, McDonald D, Geha RS, Takada H, Krause JC, et al. 2010. Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine 89: 403-425.
154. Pickrell JK, Coop G, Novembre J, Kudaravalli S, Li JZ, Absher D, Srinivasan BS, Barsh GS, Myers RM, Feldman MW, et al. 2009. Signals of recent positive selection in a worldwide sample of human populations. Genome Res 19: 826-837.
155. Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, Hergott D, Porter-Gill P, Mumy A, Kohaar I, et al. 2013. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 45: 164-171.
156. Prugnolle F, Manica A, Charpentier M, Guegan JF, Guernier V, Balloux F. 2005. Pathogen-driven selection and worldwide HLA class I diversity. Curr Biol 15: 1022-1027.
157. Puck JM, Deschenes SM, Porter JC, Dutra AS, Brown CJ, Willard HF, Henthorn PS. 1993. The interleukin-2 receptor g chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum Mol Genet 2: 1099-1104.
158. Puel A, Casanova JL. 2013. Autoantibodies against cytokines:Back to human genetics. Blood 121: 1246-1247.
159. Puel A, Ziegler SF, Buckley RH, Leonard WJ. 1998. Defective IL7R expression in T-B+NK+ severe combined immunodeficiency. Nat Genet 20: 394-397.
160. Puel A, Doffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C, Cobat A, Ouachee-Chardin M, Toulon A, Bustamante J, et al. 2010. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 207: 291-297.
161. Puel A, Cypowyj S, Bustamante J, Wright JF, Liu L, Lim HK, Migaud M, Israel L, Chrabieh M, Audry M, et al. 2011. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332: 65-68.
162. Puel A, Cypowyj S, Marodi L, Abel L, Picard C, Casanova JL. 2012. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol 12: 616-622.
163. Pulendran B, Artis D. 2012. New paradigms in type 2 immunity. Science 337: 431-435.
164. Quintana-Murci L. 2012. Genetics. Gene losses in the human genome. Science 335: 806-807.
165. Quintana-Murci L, Barreiro LB. 2010. The role played by natural selection on Mendelian traits in humans. Ann N Y Acad Sci 1214: 1-17.
166. Quintana-Murci L, Clark AG. 2013. Population genetic tools for dissecting innate immunity in humans. Nat Rev Immunol 13: 280-293.
167. Quintana-Murci L, Alcais A, Abel L, Casanova JL. 2007. Immunology in natura: Clinical, epidemiological and evolutionary genetics of infectious diseases. Nat Immunol 8: 1165-1171.
168. Raj T, Kuchroo M, Replogle JM, Raychaudhuri S, Stranger BE, De Jager PL. 2013. Common risk alleles for inflammatory diseases are targets of recent positive selection. Am J Hum Genet 92: 517-529.
169. Reith W, Satola S, Sanchez CH, Amaldi I, Lisowska-Grospierre B, Griscelli C, Hadam MR, Mach B. 1988. Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell 53: 897-906.
170. Royer-Pokora B, Kunkel LM, Monaco AP, Goff SC, Newburger PE, Baehner RL, Cole FS, Curnutte JT, Orkin SH. 1986. Cloning the gene for an inherited human disorder-chronic granulomatous disease-on the basis of its chromosomal location. Nature 322: 32-38.
171. Sabeti PC, Schaffner SF, Fry B, Lohmueller J, Varilly P, Shamovsky O, Palma A, Mikkelsen TS, Altshuler D, Lander ES. 2006. Positive natural selection in the human lineage. Science 312: 1614-1620.
172. Sabeti PC, Varilly P, Fry B, Lohmueller J, Hostetter E, Cotsapas C, Xie X, Byrne EH, McCarroll SA, Gaudet R, et al. 2007. Genome-wide detection and characterization of positive selection in human populations. Nature 449: 913-918.
173. Sancho-Shimizu V, Perez de Diego R, Lorenzo L, Halwani R, Alangari A, Israelsson E, Fabrega S, Cardon A, Maluenda J, Tatematsu M, et al. 2011. Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. J Clin Invest 121: 4889-4902.
174. Saunders MA, Hammer MF, Nachman MW. 2002. Nucleotide variability at G6pd and the signature of malarial selection in humans. Genetics 162: 1849-1861.
175. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, et al. 1995. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753.
176. Sawcer S, Ban M, Maranian M, Yeo TW, Compston A, Kirby A, Daly MJ, De Jager PL, Walsh E, Lander ES, et al. 2005. A high-density screen for linkage in multiple sclerosis. Am J Hum Genet 77: 454-467.
177. Scalzo AA, Yokoyama WM. 2008. Cmv1 and natural killer cell responses to murine cytomegalovirus infection. Curr Top Microbiol Immunol 321: 101-122.
178. Segurel L, Thompson EE, Flutre T, Lovstad J, Venkat A, Margulis SW, Moyse J, Ross S, Gamble K, Sella G, et al. 2012. The ABO blood group is a trans-species polymorphism in primates. Proc Natl Acad Sci 109: 18493-18498.
179. Sironi M, Clerici M. 2010. The hygiene hypothesis: An evolutionary perspective. Microbes Infect 12: 421-427.
180. Smith AM, Rahman FZ, Hayee BH, Graham SJ, Marks DJB, Sewell GW, Palmer CD, Wilde J, Foxwell BMJ, Gloger IS, et al. 2009. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med 206: 1883-1897.
181. Strowig T, Henao-Mejia J, Elinav E, Flavell R. 2012. Inflammasomes in health and disease. Nature 481: 278-286.
182. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, Bassendine M, Spengler U, Dore GJ, Powell E, et al. 2009. IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy. Nat Genet 41: 1100-1104.
183. Szabo SJ, Sullivan BM, Peng SL, Glimcher LH. 2003. Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol 21: 713-758.
184. Takahashi K, Yamanaka S. 2013. Induced pluripotent stem cells in medicine and biology. Development 140: 2457-2461.
185. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, et al. 2009. Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C. Nat Genet 41: 1105-1109.
186. Teahan C, Rowe P, Parker P, Totty N, Segal AW. 1987. The Xlinked chronic granulomatous disease gene codes for the Β-chain of cytochrome b-245. Nature 327: 720-721.
187. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, et al. 2009. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461: 798-801.
188. Thorsby E, Lie BA. 2005. HLA associated genetic predisposition to autoimmune diseases: Genes involved and possible mechanisms. Transpl Immunol 14: 175-182.
189. Tishkoff SA, Varkonyi R, Cahinhinan N, Abbes S, Argyropoulos G, Destro-Bisol G, Drousiotou A, Dangerfield B, Lefranc G, Loiselet J, et al. 2001. Haplotype diversity and linkage disequilibrium at human G6PD: Recent origin of alleles that confer malarial resistance. Science 293: 455-462.
190. Trapnell BC, Carey BC, Uchida K, Suzuki T. 2009. Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages. Curr Opin Immunol 21: 514-521.
191. Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, Sparkes RS, Kubagawa H, Mohandas T, Quan S, et al. 1993. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72: 279-290.
192. Uchanska-Ziegler B, Loll B, Fabian H, Hee CS, Saenger W, Ziegler A. 2012. HLA class I-associated diseases with a suspected autoimmune etiology: HLA-B27 subtypes as a model system. Eur J Cell Biol 91: 274-286.
193. Vance RE. 2010. Immunology taught by bacteria. J Clin Immunol 30: 507-511.
194. Vasseur E, Patin E, Laval G, Pajon S, Fornarino S, Crouau-Roy B, Quintana-Murci L. 2011. The selective footprints of viral pressures at the human RIG-I-like receptor family. Hum Mol Genet 20: 4462-4474.
195. Vasseur E, Boniotto M, Patin E, Laval G, Quach H, Manry J, Crouau-Roy B, Quintana-Murci L. 2012. The evolutionary landscape of cytosolic microbial sensors in humans. Am J Hum Genet 91: 27-37.
196. Verdu P, Barreiro LB, Patin E, Gessain A, Cassar O, Kidd JR, Kidd KK, Behar DM, Froment A, Heyer E, et al. 2006. Evolutionary insights into the high worldwide prevalence of MBL2 deficiency alleles. Hum Mol Genet 15: 2650-2658.
197. Vidal SM, Malo D, Marquis JF, Gros P. 2008. Forward genetic dissection of immunity to infection in the mouse. Annu Rev Immunol 26: 81-132.
198. Visscher PM, Brown MA, McCarthy MI, Yang J. 2012. Five years of GWAS discovery. Am J Hum Genet 90: 7-24.
199. Voight BF, Cotsapas C. 2012. Human genetics offers an emerging picture of common pathways and mechanisms in autoimmunity. Curr Opin Immunol 24: 552-557.
200. Voight BF, Kudaravalli S,Wen X, Pritchard JK. 2006. A map of recent positive selection in the human genome. PLoS Biol 4: e72.
201. von Bernuth H, Picard C, Jin Z, Pankla R, Xiao H, Ku CL, Chrabieh M, Mustapha IB, Ghandil P, Camcioglu Y, et al. 2008. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321: 691-696.
202. Walsh EC, Sabeti P, Hutcheson HB, Fry B, Schaffner SF, de Bakker PI, Varilly P, Palma AA, Roy J, Cooper R, et al. 2006. Searching for signals of evolutionary selection in 168 genes related to immune function. Hum Genet 119: 92-102.
203. Wlasiuk G, Nachman MW. 2010. Adaptation and constraint at Toll-like receptors in primates. Mol Biol Evol 27: 2172-2186.
204. Wlasiuk G, Khan S, Switzer WM, Nachman MW. 2009. A history of recurrent positive selection at the toll-like receptor 5 in primates. Mol Biol Evol 26: 937-949.
205. Xue Y, Daly A, Yngvadottir B, Liu M, Coop G, Kim Y, Sabeti P, Chen Y, Stalker J, Huckle E, et al. 2006. Spread of an inactive form of caspase-12 in humans is due to recent positive selection. Am J Hum Genet 78: 659-670.
206. Zhang G, Luo J, Bruckel J, Weisman MA, Schumacher HR, Khan MA, Inman RD, Mahowald M, Maksymowych WP, Martin TM, et al. 2004. Genetic studies in familial an- kylosing spondylitis susceptibility. Arthritis Rheum 50: 2246-2254.
207. Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, et al. 2007. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317: 1522-1527.
208. Zhang F, Liu H, Chen S,Wang C, Zhu C, Zhang L, Chu T, Liu D, Yan X, Liu J. 2009a. Evidence for an association of HLADRB1 *15 and DRB1*09 with leprosy and the impact of DRB1*09 on disease onset in a Chinese Han population. BMC Med Genet 10: 133.
209. Zhang FR, Huang W, Chen SM, Sun LD, Liu H, Li Y, Cui Y, Yan XX, Yang HT, Yang RD, et al. 2009b. Genomewide association study of leprosy. N Engl J Med 361: 2609-2618.
210. Zhang F, Liu H, Chen S, Low H, Sun L, Cui Y, Chu T, Li Y, Fu X, Yu Y, et al. 2011. Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy. Nat Genet 43: 1247-1251.
211. Zhang SY, Herman M, Ciancanelli MJ, Perez de Diego R, Sancho-Shimizu V, Abel L, Casanova JL. 2013. TLR3 immunity to infection in mice and humans. Curr Opin Immunol 25: 19-33.
212. Zhernakova A, Elbers CC, Ferwerda B, Romanos J, Trynka G, Dubois PC, de Kovel CG, Franke L, Oosting M, Barisani D, et al. 2010. Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection. Am J Hum Genet 86: 970-977.
213. Zinkernagel RM. 1996. Immunology taught by viruses. Science 271: 173-178.